Early deaths in pediatric acute leukemia: a population-based study

References

• Ellison LF, Pogany L, Mery LS. Childhood and adolescent cancer survival: a period analysis of data from the Canadian Cancer Registry. Eur J Cancer 2007;43:1967–1975.
   PubMed Web of Science ®Google Scholar
• Pui CH, Pei D, Pappo AS, et al. Treatment outcomes in black and white children with cancer: results from the SEER database and St Jude Children's Research Hospital, 1992 through 2007. J Clin Oncol 2012;30:2005–2012.
   PubMed Web of Science ®Google Scholar
• Smith MA, Seibel NL, Altekruse SF, et al. Outcomes for children and adolescents with cancer: challenges for the twenty-first century. J Clin Oncol 2010;28:2625–2634.
   PubMed Web of Science ®Google Scholar
• Pui CH, Evans WE. Treatment of acute lymphoblastic leukemia. N Engl J Med 2006;354:166–178.
   PubMed Web of Science ®Google Scholar
• Creutzig U, Zimmermann M, Lehrnbecher T, et al. Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: results of AML-BFM 98. J Clin Oncol 2006;24: 4499–4506.
   PubMed Web of Science ®Google Scholar
• Ravindranath Y, Chang M, Steuber CP, et al. Pediatric Oncology Group (POG) studies of acute myeloid leukemia (AML): a review of four consecutive childhood AML trials conducted between 1981 and 2000. Leukemia 2005;19:2101–2116.
   PubMed Web of Science ®Google Scholar
• Stevens RF, Hann IM, Wheatley K, Gray RG. Marked improvements in outcome with chemotherapy alone in paediatric acute myeloid leukemia: results of the United Kingdom Medical Research Council's 10th AML trial. MRC Childhood Leukaemia Working Party. Br J Haematol 1998;101:130–140.
   PubMed Web of Science ®Google Scholar
• Felix CA, Lange BJ, Chessells JM. Pediatric Acute Lymphoblastic Leukemia: Challenges and Controversies in 2000. Hematology Am Soc Hematol Educ Program 2000:285–302.
   PubMedGoogle Scholar
• Pritchard-Jones K, Dixon-Woods M, Naafs-Wilstra M, et al. Improving recruitment to clinical trials for cancer in childhood. Lancet Oncol 2008;9:392–399.
   PubMed Web of Science ®Google Scholar
• Christensen MS, Heyman M, Mottonen M, et al. Treatment-related death in childhood acute lymphoblastic leukaemia in the Nordic countries: 1992–2001. Br J Haematol 2005;131:50–58.
   PubMed Web of Science ®Google Scholar
• Blanco E, Beyene J, Maloney AM, et al. Non-relapse mortality in pediatric acute lymphoblastic leukemia: a systematic review and meta-analysis. Leuk Lymphoma 2012;53:878–885.
   PubMed Web of Science ®Google Scholar
• Greenberg ML, Barr RD, DiMonte B, et al. Childhood cancer registries in Ontario, Canada: lessons learned from a comparison of two registries. Int J Cancer 2003;105:88–91.
   PubMed Web of Science ®Google Scholar
• Greenberg ML, Barr RD, DiMonte B, et al. Childhood cancer registries in Ontario, Canada: lessons learned from a comparison of two registries. Int J Cancer 2003;105:88–91.
   PubMed Web of Science ®Google Scholar
• Creutzig U, Zimmermann M, Lehrnbecher T, et al. Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: results of AML-BFM 98. J Clin Oncol 2006;24: 4499–4506.
   PubMed Web of Science ®Google Scholar
• Creutzig U, Zimmermann M, Reinhardt D, et al. Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98. J Clin Oncol 2004;22:4384–4393.
   PubMed Web of Science ®Google Scholar
• Atlas of Childhood Cancer in Ontario. Ontario: Pediatric Oncology Group of Ontario; 2004.
   Google Scholar
• Schrappe M, Reiter A, Zimmermann M, et al. Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Berlin-Frankfurt-Munster. Leukemia 2000;14:2205–2222.
   PubMed Web of Science ®Google Scholar
• Slats AM, Egeler RM, van der Does-van den Berg A, et al. Causes of death--other than progressive leukemia--in childhood acute lymphoblastic (ALL) and myeloid leukemia (AML): the Dutch Childhood Oncology Group experience. Leukemia 2005;19:537–544.
   PubMed Web of Science ®Google Scholar
• Christensen MS, Heyman M, Mottonen M, et al. Treatment-related death in childhood acute lymphoblastic leukaemia in the Nordic countries: 1992–2001. Br J Haematol 2005;131:50–58.
   PubMed Web of Science ®Google Scholar
• Hargrave DR, Hann, II, Richards SM, et al. Progressive reduction in treatment-related deaths in Medical Research Council childhood lymphoblastic leukaemia trials from 1980 to 1997 (UKALL VIII, X and XI). Br J Haematol 2001;112:293–299.
   PubMed Web of Science ®Google Scholar
• Rubnitz JE, Lensing S, Zhou Y, et al. Death during induction therapy and first remission of acute leukemia in childhood: the St. Jude experience. Cancer 2004;101:1677–1684.
   PubMed Web of Science ®Google Scholar
• Moricke A, Reiter A, Zimmermann M, et al. Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95. Blood 2008;111:4477–4489.
   PubMed Web of Science ®Google Scholar
• Kavcic M, Fisher BT, Li Y, et al. Induction mortality and resource utilization in children treated for acute myeloid leukemia at free-standing pediatric hospitals in the United States. Cancer 2013;119:1916–1923.
   PubMed Web of Science ®Google Scholar
• Creutzig U, Zimmermann M, Reinhardt D, et al. Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98. J Clin Oncol 2004;22:4384–4393.
   PubMed Web of Science ®Google Scholar
• Hargrave DR, Hann, II, Richards SM, et al. Progressive reduction in treatment-related deaths in Medical Research Council childhood lymphoblastic leukaemia trials from 1980 to 1997 (UKALL VIII, X and XI). Br J Haematol 2001;112:293–299.
   PubMed Web of Science ®Google Scholar
• Wheeler K, Chessells JM, Bailey CC, et al. Treatment related deaths during induction and in first remission in acute lymphoblastic leukaemia: MRC UKALL X. Arch Dis Child 1996;74:101–107.
   PubMed Web of Science ®Google Scholar
• Prucker C, Attarbaschi A, Peters C, et al. Induction death and treatment-related mortality in first remission of children with acute lymphoblastic leukemia: a population-based analysis of the Austrian Berlin-Frankfurt-Munster study group. Leukemia 2009;23:1264–1269.
   PubMed Web of Science ®Google Scholar
• Tran TH, Mitchell D, Dix D, et al. Infections in children with Down syndrome and acute myeloid leukemia: a report from the Canadian Infections in AML Research Group. Infectious Agents and Cancer 2013;(in press).
   Google Scholar
• Sung L, Aplenc R, Alonzo TA, et al. Predictors and short-term outcomes of hyperleukocytosis in children with acute myeloid leukemia: a report from the Children's Oncology Group. Haematologica 2012;97:1770–1773.
   PubMed Web of Science ®Google Scholar
• Ethier MC, Blanco E, Lehrnbecher T, et al. Lack of clarity in the definition of treatment-related mortality: pediatric acute leukemia and adult acute promyelocytic leukemia as examples. Blood 2011;118: 5080–5083.
   PubMed Web of Science ®Google Scholar